已收录 268921 条政策
 政策提纲
  • 暂无提纲
Generation of a heterozygous TPM1 -E192K knock-in human induced pluripotent stem cell line using CRISPR/Cas9 system
[摘要] E192K missense mutation of TPM1 has been found in different types of cardiomyopathies (e.g., hypertrophic cardiomyopathy, dilated cardiomyopathy, and left ventricular non-compaction), leading to systolic dysfunction, diastolic dysfunction, and/or tachyarrhythmias. Here, we generated a heterozygous TPM1 -E192K knock-in human induced pluripotent stem cell (iPSC) line using CRISPR/Cas9-based genome editing system. The cells exhibit normal karyotype, typical stem cell morphology, expression of pluripotency markers and differentiation ability into three germ layers. Accordingly, this cell line could provide a useful cell resource for exploring the pathogenic role of TPM1 -E192K mutation in different types of cardiomyopathies.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 生理学
[关键词]  [时效性] 
   浏览次数:1      统一登录查看全文      激活码登录查看全文